¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acceptor control"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® quality control ÇÑ±Û Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸®
¼³¸í   
  °úÇÐÀû ¿ø¸®¸¦ ÀÀ¿ëÇÏ¿© Á¦Ç°Ç°ÁúÀÇ À¯Áö-Çâ»óÀ» ±âÇϱâ À§ÇÑ °ü¸®. ³ÐÀº ¶æÀ¸·Î´Â °¡Àå ½ÃÀ强ÀÌ ³ôÀº Á¦Ç°À» °¡Àå °æÁ¦ÀûÀ¸·Î »ý»êÇϱâ À§ÇÑ ÀÏ·ÃÀǠü°ÔÀû Á¶Ä¡¸¦ °¡¸®Å°³ª, ÀϹÝÀûÀ¸·Î´Â ¾ÕÀÇ Á¼Àº ¶æÀÇ ÇØ¼®ÀÌ Åë¿ëµÈ´Ù. ÃʱâÀÇ QC´Â ÀüÁ¦Ç°¿¡ ´ëÇØ Ä¡¼ö-Áß·®-üÀûÀ̳ª Àç·áÀÇ È­ÇÐÀû ¼ººÐ µîÀ» ÃøÁ¤Çϰí, ±×°ÍÀ» ¹Ì¸® Á¤ÇØ ³õÀº Ç°ÁúÇ¥Áذú ºñ±³ÇÏ¿© ÀûºÎ¸¦ ÆÇÁ¤Çϴ ¹æ¹ýÀÌ ÃëÇØÁ³´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü, ¹Þ°³
  • accuracy control
    Á¤È®µµ°ü¸®
  • awaking drug control law
    °¢¼ºÁ¦Á¶Àý¹ý
  • air pollution control
    ´ë±â¿À¿°°ü¸®
  • biologics control laboratory
    »ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò
  • birth control
    »ê¾ÆÁ¦ÇÑ
  • bite control
    ±³ÇÕÁ¶Á¤
  • communicable disease control
    Àü¿°º´°ü¸®
  • conception control
    ¼öÅÂÁ¶Àý
  • control
    1. ÅëÁ¦, Á¦¾î 2. ´ëÁ¶ 3. °ü¸®
  • control analysis
    ÁöµµºÐ¼®
  • control experiment
    ´ëÁ¶½ÇÇè
  • control gene
    Á¦¾îÀ¯ÀüÀÚ
  • control group
    ´ëÁ¶±º
  • control mechanism
    Á¶Àý±âÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • control
    1. ÅëÁ¦, Á¦¾î, 2. ´ëÁ¶, 3. °ü¸®
  • quality control
    Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸®
  • reflex control
    ¹Ý»çÁ¶Àý
  • safety control
    ¾ÈÀü°ü¸®
  • sugar control
    Ç÷´çÁ¶Àý
  • impulse control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö, Ãæµ¿Á¶Àýº´
  • case-control study
    ȯÀÚ´ëÁ¶±º¿¬±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü, ¹Þ°³
  • acceptor site
    ¼ö¿ëºÎÀ§
  • accuracy control
    Á¤È®µµ°ü¸®
  • air pollution control
    ´ë±â¿À¿°°ü¸®
  • awaking drug control law
    °¢¼ºÁ¦Á¶Àý¹ý
  • control analysis
    ÁöµµºÐ¼®
  • biologics control
    »ý¹°Á¦Á¦°ËÁ¤
  • biologics control laboratory
    »ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò
  • birth control
    »ê¾ÆÁ¦ÇÑ
  • bite control
    ±³ÇÕÁ¶Á¤
  • control
    ÅëÁ¦, Á¦¾î, ´ëÁ¶, °ü¸®
  • case-control study
    (¢¡retrospective) ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸
  • communicable disease control
    Àü¿°º´°ü¸®
  • conception control
    ¼öÅÂÁ¶Àý
  • control equipment
    Á¦¾îÀåÄ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü, ¼ö·Éü äÅÃÀÚ.
  • acceptor site
    ¼ö¿ëºÎÀ§
  • hydrogen acceptor
    ¼ö¼Ò¼ö¿ëü.
  • AGC (automatic gain control)
    ÀÚµ¿ °ÔÀÎ Á¶Àý
  • AGC (automatic gain control)
    ÀÚµ¿ (í»ÔÑ) °ÔÀÎ Á¶Àý (ðàï½), À̵æÀÚµ¿Á¶Àý
  • Control system
    Á¶Àý°è(ðàï½Í§)
  • Levey Jennings control chart
    ·¹ºñÁ¦´×½º°ü¸®µµ
  • Westgard quality control test
    ¿þ½ºÆ®°¡µåÁ¤µµ°ü¸®°Ë»ç¹ý
  • accuracy control
    Á¤È®¼º Á¶Àý
  • admission by legal control
    Á¶Ä¡ÀÔ¿ø.
  • air pollution control
    ´ë±â¿À¿°¹æÁö<±ÔÁ¦> (ÊÙËÑ̤<˻̡>).
  • gate control system
    °ü¹®Á¶Á¤ÀåÄ¡(μڦðàïÚíûöÇ).
  • gate control theory
    (°ü)¹®Á¶Àý¼³(μڦðàï½àã).
  • gonorrhea control
    ÀÓÁú°ü¸®.
  • hospital infection control
    ¿ø³»<º´¿ø>°¨¿°°ü¸®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü, ¼ö·Éü äÅÃÀÚ.
  • acceptor site
    ¼ö¿ëºÎÀ§
  • hydrogen acceptor
    ¼ö¼Ò¼ö¿ëü.
  • accuracy control
    Á¤È®¼º Á¶Àý
  • admission by legal control
    Á¶Ä¡ÀÔ¿ø.
  • air pollution control
    ´ë±â¿À¿°¹æÁö<±ÔÁ¦> (ÊÙËÑ̤<˻̡>).
  • awaking drug control law
    °¢¼ºÁ¦Á¶Àý¹ý.
  • biologics control
    »ý¹°Á¦Á¦°ËÁ¤(ÊÙÌ¡Ì¡Ë§Ëø).
  • biologics control
    »ý¹°Á¦Á¦°ËÁ¤(¡­ð²ð¥ËþïÒ).
  • biologics control laboratory
    [º´¸®,¹Ì»ý,±â»ý,¸é¿ª,¹ÙÀÌ,¿¹¹æ]»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò(Ë×ËÑ̡̡˴ËöËàÌ´ËÛ).
  • biologics control laboratory
    º´¸®,¹Ì»ý,±â»ý,¸é¿ª,¹ÙÀÌ,¿¹¹æ»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò(ßæÚªð²ð¥Î·ìµãËúÐá¶).
  • birth control
    °£ È£ »ê¾ÆÁ¦ÇÑ(ß§ä®ð¤ùÚ), ¼öÅÂÁ¶Àý(áô÷Ãðàï½).
  • birth control
    °£ È£ »ê¾ÆÁ¦ÇÑ(Ë×Ëâ̡̰). ¼öÅÂÁ¶Àý
  • bite control
    ±³ÇÕÁ¶Á¤(ÎáùêðàïÚ).
  • cancer control program
    ¾Ï°ü¸®°èȹ(ËâË´ËöË­Ì·), ¾Ï¿¹¹æ»ç¾÷.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insect control
    °ïÃæ±¸Á¦, °ïÃæ¹æÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor control
    ¼ö¿ëü Á¦¾î (â¥é»ô÷ ð¤åÙ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor-control ratio
    ¼ö¿ëü Á¦¾îÀ² (â¥é»ô÷ ð¤åÙëÒ)
  • acceptor RNA
    ¼ö¿ë(â¥é»)RNA
  • acceptor site
    ¼ö¿ëºÎÀ§ (â¥é»Ý»êÈ)
  • electron acceptor
    ÀüÀÚ ¼ö³³Ã¼(ï³í­ áôÒ¡ô÷)
  • low-energy phophate acceptor
    Àú(î¸)¿¡³ÊÁö Àλê¼ö³³Ã¼(×òß«áôÒ¡ô÷)
  • phosphate acceptor peptide
    Àλê¼ö¿ë(×òß«áôé») ÆéŸÀ̵å
  • adenylate control hypothesis
    ¾Æµ¥´Ò»ê(ß«)Á¶Àý¼³(ðàï½àã)
  • autogenous control
    ÀÚÀÎÁ¶Àý (í»ì×ðàï½)
  • control
    "´ëÁ¶(ÓßðÎ), Á¶Àý(ðàï½), Á¦¾î(ð¤åÙ)"
  • control analysis
    ´ëÁ¶ ºÐ¼®(ÓßðÎÝÂà°)
  • control strengh
    Á¶Àý °­µµ(ðàï½Ë­Óø)
  • negative control
    À½Á¦¾î(ëäð¤åÙ)
  • negative gene control
    À½À¯ÀüÀÚÁ¦¾î(ëäë¶îîí­ð¤åÙ)
  • positive control
    "°¡Á¶Àý(ʦðàï½), ¾ç¼ºÁ¶Àý(åÕàõðàï½)"
  • positive gene control
    "°¡À¯ÀüÀÚÁ¶Àý(ʦë¶îîí­ðàï½), ¾ç¼ºÀ¯ÀüÀÚÁ¶Àý, (åÕàõë¶îîí­ðàï½)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü
  • AGC [=automatic gain control]
    ÀÚµ¿°ÔÀÎÁ¶Àý
  • control
    ´ëÁ¶, Á¶Àý, Á¦¾î, °ü¸®, ±ÔÁ¦, ¹æÁ¦
  • control group
    ´ëÁ¶±º
  • equipment quality control
    ÀåÄ¡ÀÇ ¼º´É°ü¸®
  • pulse control unit
    ¸Æ¹ÚÁ¶Àý´ÜÀ§
  • quality control
    È­Áú°ü¸®, ǰÁú°ü¸®
  • remote control
    ¿ø°ÝÁ¶Á¾, ¿ø°ÝÁ¶ÀÛ
  • time gain control
    ½Ã°£°ÔÀÎÁ¶Àý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
D-A donor-acceptor
EDA electrodermal activity; electrodermal audiometry; electrolyte-deficient agar; electron donor accepto...
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
BCM B-cell maturation; birth control medication; blood-clotting mechanism effects; body cell mass; body ...
CDC calculated date of confinement; cancer diagnosis center; capillary diffusion capacity; cell division...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
A D)-acceptor
Control control
control group control
CG 2--Control
ICR 3'-internal control region
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hydrogen acceptor
    ¼ö¼Ò ¼ö¿ëü
    ½Åü Á¶Á÷ Áß¿¡¼­ Çø±âÀûÀ¸·Î ÀϾ´Â »êÈ­ ȯ¿ø ¹ÝÀÀ¿¡¼­ ȯ¿øµÇ´Â ¹°Áú.
  • admission by legal control
    Á¶Ä¡ ÀÔ¿ø
  • birth control
    ÇÇÀÓ¹ý
    ¼öŸ¦ ÀΰøÀûÀ¸·Î Á¶ÀýÇÏ´Â ÀÏ. Àü¿¡´Â »ê¾Æ Á¦ÇÑ, Ãâ»ê Á¶ÀýÀ̶ó°í ÇßÀ¸³ª Á¶Àý ´ë»óÀº ºÐ¸¸ÀÌ ¾Æ´Ï°í ¼öÅÂÀ̱⠶§¹®¿¡ ¼öÅ Á¶Àý·Î °³Á¤µÇ¾ú´Ù. ¸ðüÀÇ °Ç°­À̳ª °æÁ¦ÀûÀÎ ÀÌÀ¯ µîÀ¸·Î ÀÓ½ÅÇØ¼­´Â °ï¶õÇÑ »çÁ¤ÀÌ ÀÖÀ» ¶§ ÇÇÀÓÀ» °è¼ÓÇϰí, ¾ÆÀ̰¡ ÇÊ¿äÇØÁö¸é ÇÇÀÓÀ» ÁßÁöÇϰí ÀÓ½ÅÇÒ ¼ö ÀÖµµ·Ï ÀÎÀ§ÀûÀÎ ¼ö´ÜÀ» »ç¿ëÇØ¼­ ¼öŸ¦ ÀΰøÀûÀ¸·Î Á¶ÀýÇÏ¿© »ê¾Æ¸¦ Á¦ÇÑÇÏ´Â °ÍÀÌ´Ù. ÀÌ¹Ì ÀÓ½ÅÇÑ °ÍÀ» ÀΰøÀûÀ¸·Î ÁßÀýÇÏ´Â °ÍÀº ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾Ê´Â´Ù. Áï, ÇÇÀÓÀÇ ½ÇÆÐ´Â µµ¸®°¡ ¾ø±â ¶§¹®¿¡ ¹Ù¸¥ ÇÇÀÓÀÇ Áö½ÄÀ» ¾ò¾î ÀûÀýÇÑ ÇÇÀÓ¹ýÀ» ¼±ÅÃÇØ¼­ ¹Ù¸£°Ô ½ÃÇàÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù. ¼öÅ Á¶Àý¿¡ ÀÀ¿ëµÇ´Â ÇÇÀÓ¹ýÀº ¼öÁ¤ ÀúÁö¹ý°ú ¼öÅ ÀúÁö¹ýÀ¸·Î ´ëº°µÇÁö¸¸ ¸ðµÎ ÀϽÃÀûÀÎ ÇÇÀÓ¹ýÀÌ´Ù. À̰ÍÀº ±¹°¡°¡ ÁÖüÀÎ °æ¿ì¿¡´Â Àα¸ Á¤Ã¥ÀÌ µÇ¸ç, °¡Á¤ÀÌ ÁÖüÀÎ °æ¿ì¿¡´Â °¡Á· °èȹÀÌ µÇ´Â °¡Àå ÇÕ¸®ÀûÀÎ ¼ö´ÜÀÌ´Ù. ½Ç¿ëÀûÀÎ ¸é¿¡¼­ ºÐ·ùÇÑ ÇÇÀÓ¹ýÀº ´ÙÀ½°ú °°´Ù. ¡¼¹è¶õÀÏ ÀüÈÄÀÇ ¼º±³¸¦ ÇÇÇÏ´Â ¹æ¹ý¡½ ¹è¶õÀÏ ÀüÈÄ ¼öÀϰ£À» ±Ý¿åÇÔÀ¸·Î½á ¼öÁ¤À» ¹Ì¸® ¸·´Â °ÍÀ¸·Î, ¹è¶õÀÏÀ» ¿¹»óÇÏ´Â ¹æ¹ý¿¡´Â 2°¡Áö°¡ ÀÖ´Ù. ¨ç ¿À±â³ë½Ä ¼öÅ Á¶Àý¹ý : Çѱ¹¿¡¼­ °¡Àå ³Î¸® º¸±ÞµÇ¾î ÀÖ´Â ¹æ¹ýÀ¸·Î, ¿ù°æ ÁֱⰡ Á¤È®ÇÏ°Ô µ¹¾Æ¿À´Â ¿©¼º¿¡°Ô¸¸ Àû¿ëÀÌ °¡´ÉÇÏ´Ù. 28ÀÏÇüÀÎ ¿©¼ºÀÇ °æ¿ì ¿ù°æ Á¦1ÀϰºÎÅÍ ¼¼¾î¼­ Á¦14Àϰ°¡ µÇ´Â ³¯ÀÇ Àü 3Àϰ£°ú ÈÄ 2Àϰ£ÀÌ °¡Àå ÀÓ½ÅÇϱ⠽¬¿î ³¯·Î º¸°í ÀÌ ±â°£Àº ¼º±³¸¦ ÇÇÇÑ´Ù. ÀÌ ¹æ¹ýÀº ¿ù°æ ÁֱⰡ ºÒ±ÔÄ¢ÇÑ ¿©¼ºÀÇ °æ¿ì¿¡´Â ½ÇÆÐÀÇ È®·üÀÌ Å©´Ù. ¨è ±âÃÊ Ã¼¿ÂÇ¥¸¦ ÀÀ¿ëÇÏ´Â ¹æ¹ý : ¸ÅÀÏ ±âÃÊ Ã¼¿ÂÀ» ÃøÁ¤Çؼ­ ±âÃÊ Ã¼¿Â °î¼±ÀÌ °í¿Â»óÀÌ µÇ¾î 2ÀÏÀÌ °æ°úÇßÀ» ¶§´Â °ÅÀÇ ÀÓ½ÅÇÏÁö ¾Ê´Â °ÍÀ¸·Î ³ªÅ¸³ª ÀÖ¾î 3ÀÏ ÀÌÈĺÎÅÍ ¼º±³¸¦ °®´Â ¹æ¹ýÀÌÁö¸¸, °í¿Â»óÀÎÁö Àú¿Â»óÀÎÁö¸¦ Á¤ÇϱⰡ ¶§·Î´Â °ï¶õÇÑ ¶§°¡ ÀÖ´Ù. ¡¼³²¼ºÀÌ ÇÇÀÓ µµ±¸³ª ¾àǰÀ» »ç¿ëÇÏ´Â ¹æ¹ý¡½ ³²¼ºÀÌ ¼º±³ ¶§ Äܵ¼À» ½á¼­ ¼öÁ¤À» ÀúÁöÇÏ´Â ¹æ¹ýÀÌ °¡Àå ÀϹÝÀûÀÌ´Ù. Äܵ¼Àº ³²¼º ¼º±â¿¡ ¾º¿ö¼­ »ç¿ëÇÏ´Â ¾ãÀº °í¹« Á¦Ç°ÀÎ Á¡¿¡¼­ ³²¼ºÀÌ »ç¿ë°¨À» °¡Áö°Ô ÇÑ´Ù´Â °áÁ¡ÀÌ ÀÖ°í, ¿©¼º¿¡°Ô´Â ½É¸®ÀûÀÎ ¹®Á¦¸¦ Æ÷ÇÔÇÏ¿© ¿©·¯ °¡Áö °áÁ¡ÀÌ ÁöÀûµÇ°í ÀÖÁö¸¸, ½ÇÆÐÀ²ÀÌ ³·°í ÀϹÝÀûÀ¸·Î ½±°Ô ±¸ÇÒ ¼ö ÀÖÀ¸¸ç ´©±¸³ª »ç¿ëÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÌ ´Ù¸¥ ¹æ¹ý¿¡ ºñÇØ ÀåÁ¡ÀÌ´Ù. ƯÈ÷ ÃÖ±Ù¿¡´Â °í¹«ÀÇ ÁúÀÌ °³·®µÇ°í Á¦Ç°ÀÇ Ç°ÁúÀÌ Çâ»óµÇ¾î ÆÄ¼ÕÀÇ ¿ì·Áµµ ¾ø´Ù. ÀÌ ¹Û¿¡ Á¤ÀÚ¸¦ ¸¸µå´Â ÈûÀ» ¾àÈ­½Ãų ¸ñÀûÀ¸·Î ³²¼º¿¡°Ô ÇÇÀÓ ¾àÀ» ¾²°Ô ÇÏ´Â °æ¿ìµµ ÀÖÀ¸³ª, ÇÇÀÓÀÇ ¸ñÀûÀº ´Þ¼ºÇß´Ù ÇØµµ °¡²û ³²¼ºÀÇ ¼º¿åÀ» ÀúÇϽÃŲ´Ù ÇÏ¿© ½Ç¿ëµÇÁö ¾Ê°í ÀÖ´Ù. ¡¼ÁßÀý ¼º±³¹ý¡½»çÁ¤ Àü¿¡ ¼º±³¸¦ Áß´ÜÇϰí Áú ¿ÜºÎ¿¡ »çÁ¤ÇÏ´Â ¹æ¹ýÀε¥ Áú ¾È¿¡ Á¤¾×À» µé¿©º¸³»Áö ¾Êµµ·Ï ÇØ¼­ ÀÓ½ÅÀ» ÇÇÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. ÀÌ ¹æ¹ýÀº Ưº°ÇÑ ±â±¸¸¦ ÇÊ¿ä·Î ÇÏÁö ¾ÊÀ¸¸ç ¾î·Á¿ò ¾øÀÌ ÇÒ ¼ö ÀÖ´Â ÀåÁ¡µµ ÀÖÁö¸¸, ÇÇÀÓÀ̶ó´Â ¸ñÀû ¶§¹®¿¡ ¼º°¨À» Èñ»ýÇÏ°Ô µÇ´Â °æÇâÀÌ °­ÇÏ´Ù. ´õ¿íÀÌ °áÁ¤ÀûÀÎ °áÁ¡Àº ÀÓ½ÅÀÇ À§Çèµµ Å©´Ù´Â Á¡ÀÌ´Ù. ¡¼¿©¼ºÀÌ ±â±¸¸¦ »ç¿ëÇÏ´Â ¹æ¹ý¡½¨ç Æä¼­¸®
  • bite control
    ±³ÇÕ Á¶Á¤
    ±³ÇÕ°£ °ü°è³ª ±× Ç¥½Ã¸¦ Á¶Á¤ÇÏ´Â °Í.
  • case control study
    ȯÀÚ ´ëÁ¶ ¿¬±¸
  • control animal
    ´ëÁ¶ µ¿¹°
  • control equipment
    Á¦¾î ÀåÄ¡
  • control gene
    Á¦¾î À¯ÀüÀÚ
  • control of bleeding
    ÁöÇ÷¹ý
  • control panel
    Á¶Á¾ÆÇ
  • control system
    Á¶Àý°è
  • control valve
    Á¶Àý ¹ëºê, Á¶ÀýÆÇ
  • laser hazard control measure
    ·¹ÀÌÀú À§ÇØÁ¶Àý¹ý
    ·¹ÀÌÀú°¡ Áö´Ñ ¾öû³­ ¿¡³ÊÁö´Â ÀÎü¿¡ ÇØ°¡ µÉ ¼ö ÀÖÀ¸¹Ç·Î µÇµµ·Ï ·¹ÀÌÀú¸¦ »ç¿ëÇÏ´Â »ç¶÷µéÀÌ ¼Õ»óÀ» ¹ÞÁö ¾Êµµ·Ï ÇÏ´Â ¹æ¹ý.
  • leprosy control
    ³ª °ü¸®
    °³³ä»ó, ÁÖ¹ÎÀ» ³ª±ÕÀÇ Àü¿°À¸·ÎºÎÅÍ º¸È£ÇÏ´Â ¿¹¹æ °ü¸®¿Í, ³ªÈ¯ÀÚ¸¦ ³ª±ÕÀ¸·ÎºÎÅÍ ¿À´Â À°Ã¼Àû, Á¤½ÅÀû °íÅëÀ» ´ú¾î ÁÖ´Â Áø·á °ü¸®ÀÇ µÎ °¡Áö·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ¨ç ¿¹¹æ °ü¸®´Â Àü¿°¿øÀ» Â÷´ÜÇÏ´Â °ÍÀ» ¸»Çϴµ¥, ³ª ȯÀÚ¸¦ °Ý¸®ÇÔÀ¸·Î½á ³ªº´ÀÇ Àü¿°¿øÀÌ Â÷´ÜµÈ´Ù°í »ý°¢Çß´ø ½Ã´ë¿¡´Â ³ª ȯÀÚ Àü¿øÀ» °Ý¸® ¼ö¿ëÇÏ¿´´Ù. ±×·¯³ª Àüü ³ª ȯÀÚ Áß ±ØÈ÷ ÀϺÎÀÇ ¹Ì°ü¸®ÇÏ¿¡ Àִ ȯÀÚ¸¸ÀÌ Àü¿°¿øÀÌ µÈ´Ù´Â »ç½ÇÀÌ ¹àÇôÁø ¿À´Ã³¯¿¡´Â, ³ª ȯÀÚ·Î È®ÀÎÀÌ µÇ¾î ¾àÁ¦ Åõ¿©°¡ ½ÃÀÛµÈ ÈÄ¿¡´Â Àü¿°¿øÀÌ µÉ ¼ö ¾ø´Ù´Â °á·Ð¿¡ À̸£·¶´Ù. ÀÌ¿¡ µû¶ó ¿À´Ã³¯¿¡´Â ÀÏ¹Ý ÇǺΠÁúȯÀÚ¿Í °°ÀÌ ÀÚÀ¯·ÎÀÌ »ý¾÷¿¡ Á¾»çÇϸç Áø·á¸¦ ¹Þ°í ÀÖ´Ù. ¨è Áø·á °ü¸®´Â Àǻ簡 Á¤È®ÇÑ Áø´Ü°ú º´Çü ºÐ·ù¸¦ ¹ÙÅÁÀ¸·Î ÀûÇÕÇÑ Ã³¹æÀ» ³»¸®°í ȯÀÚ°¡ ¼º½ÇÇÏ°Ô ¾àÀ» º¹¿ëÇÏ´Â °ÍÀÌ´Ù. ¹®Á¦´Â ³ªº´ÀÌ ¸¸¼ºÀûÀ¸·Î °æ°úÇÏ´Â Àå±â ÁúȯÀε¥´Ù Ä¡·áÀÇ ¼º°ú°¡ Áï½Ã ³ªÅ¸³ªÁö ¾ÊÀ¸¹Ç·Î 󹿰ú º¹¾àÀÌ ³ªÅÂÇØÁ® Ä¡·á°¡ ºÒ±ÔÄ¢ÇØÁö°í ¾àÁ¦ ³»¼ºÀ» ¹ßÀü½ÃŰ´Â µ¥ µû¸¥ °ü¸®»óÀÇ ¾î·Á¿òÀÌ ÀÖ´Ù. ³ªº´¿¡ ´ëÇÑ Æí°ßÀ» ¾ø¾Ö°í ±¹¹ÎÀû ÀÌÇØ¿Í Âü¿©¿¡ ÀÇÇØ Á¶±â ¹ß°ß ¹× Ä¡·á¿¡ ÀÓÇÑ´Ù¸é ³ªº´ °ü¸®¸¦ À§ÇÑ Æ¯¼ö ½Ã¼³À̳ª ±â°üÀÌ ÇÊ¿ä¾ø°Ô µÉ °ÍÀÌ´Ù.
  • nociceptive control
    Ä§ÇØ ¼ö¿ë¼º Á¶Àý, À¯ÇØ ¼ö¿ë¼º Á¶Àý
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
acceptor control <biochemistry> The regulation of the respiration rate, governed by ADP's ability to be a phosphate group acceptor.
(06 May 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acceptor A compound that will take up a chemical group (e.g., an amine group, a methyl group, a carbamoyl group) from another compound (the donor); under the action of alanine transaminase, l-glutamic acid is an amine donor while pyruvic acid is an amine acceptor.
Origin: L. Ac-cipio, pp. -ceptus, to accept
(05 Mar 2000)
acceptor RNA rNA
acceptor site The ribosomal binding site for the aminoacyl-tRNA during protein synthesis.
(05 Mar 2000)
acceptor splicing site Boundary between the right end of an intron and the left end of the adjacent exon.
Synonym: acceptor splicing site.
(05 Mar 2000)
alcohol dehydrogenase (acceptor) An oxidoreductase that reversibly converts primary alcohols to aldehydes with an H acceptor other than NADP+.
(05 Mar 2000)
phenylglyoxylate - acceptor oxidoreductase <enzyme> Requires coenzyme a; converts phenylglyoxylate to benzoyl-CoA with release of co2
Registry number: EC 1.2.99.-
Synonym: phenylglyoxylate oxidoreductase (acylating)
(26 Jun 1999)
proton acceptor <chemistry> A base, an anionic substance that acceptsa proton during an acid-basereaction.
(09 Oct 1997)
hydrogen acceptor A molecule that, in conjunction with a tissue enzyme system, carries hydrogen from one metabolite (oxidant) to another (reductant) or to molecular oxygen to form H2O.
Synonym: hydrogen acceptor.
(05 Mar 2000)
dimethylsulfide - acceptor oxidoreductase <enzyme> Contains b-type haem and pterin molybdenum cofactor; distinct from dimethylsulfoxide reductase; mw 152 kD; from rhodobacter sulfidophilus
Registry number: EC 1.8.99.-
Synonym: me2so-acceptor oxidoreductase, molybdenum oxotransferase
(26 Jun 1999)
electron acceptor <chemistry> A molecule or compound that gets electrons during an oxidation-reduction reaction.
(19 Jan 1998)
L-sorbose-(acceptor) 5-oxidoreductase <enzyme> Fad-dependent enzyme that catalyses conversion of l-sorbose to l-sorbosone; 58-kD membrane protein in gluconobacter oxydans
Registry number: EC 1.1.99.12
Synonym: l-sorbose dehydrogenase, sdh enzyme
(26 Jun 1999)
anticipatory control <physiology> The regulation of a system or process based on anticipated events, this isa feed-forward rather than a feedback system.
(09 Oct 1997)
assist-control ventilation Artificial respiration in which inspiration is produced automatically after a set interval if the person has not already begun to inspire.
Compare: assisted ventilation, controlled ventilation.
(05 Mar 2000)
autogenous control <molecular biology> Regulation of how much a gene gets transcribed by the gene's own products.
(02 Jan 1998)
aversive control <psychology> Control of the behaviour of another individual by use of psychologically noxious means; e.g., attempting to force better study habits by withholding a child's allowance, or withholding sexual contact unless the partner complies with a request.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¾îÀ½ ÀμöÀÎ
  • bring under control
    Á¦¾î(¾ïÁ¦)ÇÏ´Ù; (ºÒÀ»)²ô´Ù
  • control
    ¾ïÁ¦ÇÏ´Ù,°ü¸®ÇÏ´Ù,Áö¹è,¾ïÁ¦
  • self-control
    ÀÚÁ¦
  • atomic control
    ¿øÀÚ·Â °ü¸® 
  • atonic control
    ¿øÀڷ°ü¸® 6
  • automatic train control
    ¿­Â÷ÀÚµ¿Á¦¾îÀåÄ¡
  • birth control
    »ê¾Æ Á¦ÇÑ
  • central control station
    Áß¾ÓÁ¦¾î±¹
  • civilian control
    ¹®°ü ¿ìÀ§(Áö¹è)
  • conception control
    ¼öÅ Á¶Àý;ÇÇÀÓ
  • control
    Áö¹è;´Ü¼Ó;°ü¸®;°¨µ¶(±Ç);¾ïÁ¦;Á¦¾î;±ÔÁ¦;Á¦±¸(·Â);ÄÁÆ®·Ñ;ÅëÁ¦(°üÁ¦)¼ö´Ü;(±â°èÀÇ)Á¶Á¾(Á¦¾î)ÀåÄ¡;(½ÇÇèÀÇ)´ëÁ¶Ç¥ÁØ;´ëÁ¶±¸;¿µ¸Å¸¦ Áö¹èÇÏ´Â Áö¹è·É;(ÀÚµ¿Â÷°æÁֵ¼­ °£´ÜÇÑ ¼ö¸®¸¦ À§ÇÑ)°æÁÖ Áߴܱ¸¿ª;Á¦¾î;Áö¹èÇÏ´Ù;ÅëÁ¦(°üÁ¦)ÇÏ´Ù;°¨µ¶ÇÏ´Ù;°ü¸®ÇÏ´Ù;¾ïÁ¦(Á¦¾î)ÇÏ´Ù;(
  • control board
    Á¦¾î¹Ý
  • control booth
    (¶óµð¿À.TV)Á¦¾î½Ç;Á¶Á¤½Ç
  • control chart
    °ü¸®µµ(ƯÈ÷ Á¦Ç° ǰÁúÀÇ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á